Pfizer says no more stock buybacks, acquisitions i
Post# of 72440
Quote:
Our strategy for M&A it is to be able to have Phase II, Phase III programs priority Phase II Phase III, which could become potential medicines in the period ’25, ’26, ’27, ’28 so that we can augment our internal pipeline
https://endpts.com/putting-buybacks-on-hold-p...n-alerted/